# Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses

> **NCT01914952** · NA · COMPLETED · sponsor: **Metabolic Technologies Inc.** · enrollment: 11 (actual)

## Conditions studied

- Focus of the Study is to Examine Plasma HMB Levels After Oral HMB Supplementation

## Interventions

- **DIETARY_SUPPLEMENT:** CaHMB capsule
- **DIETARY_SUPPLEMENT:** HMB free acid gelcap
- **DIETARY_SUPPLEMENT:** HMB free acid mixed in water
- **DIETARY_SUPPLEMENT:** CaHMB in water
- **DIETARY_SUPPLEMENT:** HMB free acid

## Key facts

- **NCT ID:** NCT01914952
- **Lead sponsor:** Metabolic Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01914952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01914952, "Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01914952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*